SCHEMBL4854115

SCHEMBL4854115

COc1ccc(C(=O)C=Cc2cccc(OCCN(C)C)c2)c(OC)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.63
MEN1 O00255 2/20 0.63
KMT2A Q03164 2/20 0.63
NPC1 O15118 1/20 0.63
RAB9A P51151 1/20 0.63
ABCG2 Q9UNQ0 6/20 0.60
APP P05067 2/20 0.60
TNFRSF1A P19438 1/20 0.59
USP2 O75604 1/20 0.58
MAPK1 P28482 1/20 0.58
TLR9 Q9NR96 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
CYP1A2 P05177 2/20 0.56
CYP3A4 P08684 2/20 0.56
CYP2D6 P10635 2/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
CYP1A1 P04798 1/20 0.56
CYP1B1 Q16678 1/20 0.56
XDH P47989 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4853023 0.95 MAPT (0.61) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL4845309 0.92 ABCG2 (0.60) MAPTABCG2APPCYP1A2CYP3A4
SCHEMBL4851228 0.92 ABCG2 (0.60) MAPTABCG2APPCYP1A2CYP3A4
SCHEMBL4848357 0.89 MAOB (0.60) ABCG2APPCYP1A2CYP3A4CYP2D6
SCHEMBL4851385 0.89 APP (0.59) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL4846963 0.87 TUBB1 (0.56) ABCG2APPCYP1A2CYP3A4CYP2D6
SCHEMBL4852954 0.87 ABCG2 (0.59) MAPTABCG2APPCYP1A2CYP3A4
SCHEMBL29443563 0.87 MAPT (0.82) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL4846088 0.85 MAOB (0.71) MAPTMEN1KMT2AAPPTNFRSF1A
SCHEMBL4853318 0.85 MAOB (0.62) APPBCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed